

Author: Simbre Valeriano C. Duffy Sarah A. Dadlani Gul H. Miller Tracie L. Lipshultz Steven E.
Publisher: Adis International
ISSN: 1174-5878
Source: Pediatric Drugs, Vol.7, Iss.3, 2005-01, pp. : 187-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. :